<DOC>
	<DOCNO>NCT01877447</DOCNO>
	<brief_summary>Transcranial direct cranial stimulation ( tDCS ) novel technique base application weak electrical current scalp two electrode - anode , facilitate neuronal depolarization , cathode , lead neuronal hyper-polarization . Recently , several open-label sham-controlled clinical trial apply daily tDCS session treatment major depressive disorder ( MDD ) . Theoretically , tDCS display depression improvement anodal stimulation leave dorsolateral prefrontal , induce excitability-enhancing effect area , hypoactive acute depressive episode . The present study aim compare two different tDCS protocol : ( 1 ) active anodic stimulation leave dorsolateral prefrontal cortex cathode place extra cephalic area ; ( 2 ) active cathode place right dorsolateral prefrontal cortex anode place extra cephalic area .</brief_summary>
	<brief_title>Comparison Two tDCS Protocols Treatment Major Depressive Disorder</brief_title>
	<detailed_description>The present research protocol evaluate clinical effect two different tDCS protocol : ( 1 ) active anodic stimulation leave dorsolateral prefrontal cortex cathode place extra cephalic area ; ( 2 ) active cathode place right dorsolateral prefrontal cortex anode place extra cephalic area . Patients clinically evaluate Diagnostic Statistical Manual Mental Disorders Fourth Edition ( DSM-IV ) criterion depression . Symptoms intensity rat accord The Hamilton Depression Scale ( HAMD -17 item ) - main outcome . Patients score high 16 include . Patients active neurological severe disorder ( cancer auto-imune disorder ) exclude . The present study double-blinded , control , randomize trial 30 patient depression . The intervention protocol consist 15 consecutive daily tDCS session ( skip weekend ) . After meet eligibility criterion , patient randomize ( computer generate list ) one two intervention group . We use direct current 2.0 milliampere ( mA ) 30 min . The 35 cm2-rubber electrode wrap cotton material , moisten saline reduce impedance . Patients clinically assess baseline end 6 week . Main outcome base HAMD-17 item final endpoint 6-weeks , secondary outcome assess Beck Depression Inventory ( 21 item ) 6 week . Other evaluation scale include Beck Anxiety Inventory , Hamilton Anxiety Scale Safety cognitive assessment perform The Montreal Cognitive Assessment , adverse effect scale clinical evaluation train physician .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>patient age 1889 year , depression diagnosis accord Diagnostic Statistical Manual Mental Disorders Fourth Edition ( DSMiV ) ; HAMD score high 16 ; accordance inform consent active neurologic severe disorder ( cancer autoimune ) pregnancy ; need hospitalization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>tDCS</keyword>
	<keyword>Brain stimulation</keyword>
	<keyword>depressive disorder</keyword>
</DOC>